Key Highlights

Risk & Performance

Pipeline Risk Assessment

Based on historical performance

Low Risk

Score: 30/100

Failure Rate

14.3%

1 terminated/withdrawn out of 7 trials

Success Rate

83.3%

-3.2% vs industry average

Late-Stage Pipeline

57%

4 trials in Phase 3/4

Results Transparency

60%

3 of 5 completed trials have results

Key Signals

3 with results

Enrollment Performance

Analytics

Phase 4

4(57.1%)

N/A

2(28.6%)

Phase 2

1(14.3%)

7Total

Phase 4(4)

N/A(2)

Phase 2(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (7)

Showing 7 of 7 trials

NCT05746377Phase 4Unknown

Metoclopramide in Upper Gastrointestinal Bleed

Role: lead

NCT00202800Phase 2Completed

Phase II Trial to Evaluate Gemcitabine and Etoposide for Locally Advanced or Metastatic Pancreatic Cancer

Role: collaborator

NCT03647397Not ApplicableCompleted

PECO Air Purification in Hospital Rooms to Improve Health Outcomes for Pediatric Respiratory Distress

Role: collaborator

NCT01788761Not ApplicableTerminated

The Effects of Probiotic Supplementation on Extremely Low Birthweight Infants

Role: lead

NCT01122238Phase 4Completed

Identifying Treatments to Motivate Smokers to Quit

Role: collaborator

NCT01116986Phase 4Completed

Identifying Optimal Smoking Cessation Intervention Components (Cessation)

Role: collaborator

NCT01120704Phase 4Completed

Evaluation of Treatments to Improve Smoking Cessation Medication Adherence

Role: collaborator

All 7 trials loaded